Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lateral habenula (LHb) consists of a small, phylogenetically conserved nucleus situated in the epithalamus, above the thalamus and adjacent to the third ventricle[1][6]. LHb neurons, predominantly glutamatergic, act as a central relay for negative valence signals by inhibiting midbrain dopaminergic, serotonergic, and GABAergic systems through direct and polysynaptic pathways[1][3][5][6]. Activity in these neurons encodes aversive stimuli, negative prediction errors (signals of lack of expected reward), and regulates adaptive behaviors relating to motivation, response flexibility, and learning from negative outcomes[1][3][5]. Hyperactivity or pathological burst firing of LHb neurons is associated with depression and treatment-resistant mood disorders, while modulation of their activity (pharmacologically or by deep brain stimulation) is under investigation as a potential intervention for neuropsychiatric disease[1][5][6]. LHb neuron populations are diverse, with at least four transcriptionally defined subtypes, each exhibiting distinct anatomical connections and functional specializations, notably in controlling subcortical monoamine nuclei[2][4]. In summary, "lateral habenula neuronal activity" is not itself a canonical molecular target but describes the functional behavior of a neuron population critical for reward/aversion processing and implicated in neuropsychiatric disease[1][5][6].
NMDA receptor antagonism (e.g., ketamine blocks pathological NMDA-dependent burst firing in LHb neurons). Chemogenetic inhibition (e.g., Gi/o-coupled DREADD reduces LHb neuronal activity in preclinical studies).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lateral habenula neuron (LHb neuron).